Close Menu

NEW YORK (GenomeWeb) – SQream Technologies said today that it has raised $7.4 million in private funding , which it will use to grow its business, particularly in North America.

San Francisco-based Blumberg Capital led the funding With the investment, Alon Lifshitz, a partner at Blumberg Capital, will join SQream's board of directors. To date, SQream has raised $11 million from investors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Rady Children's Institute for Genomic Medicine and Deloitte are looking into the use of drones to transport samples for testing. 

Direct-to-consumer genetic testing firm 23andMe is laying off about 100 people.

Researchers from Northwestern University examined dust for antibiotic-resistance genes, New Scientist reports. 

In Science this week: researchers present a computational method for predicting cellular differentiation state from single-cell RNA sequencing data, and more.